Kbc Group Nv Dyne Therapeutics, Inc. Transaction History
Kbc Group Nv
- $33.1 Billion
- Q3 2024
A detailed history of Kbc Group Nv transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 2,157 shares of DYN stock, worth $63,156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,157
Previous 1,406
53.41%
Holding current value
$63,156
Previous $50,000
54.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
210Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$235 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$216 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$201 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$200 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$199 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.52B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...